Eloisa UrrechagaIgartua
Eloisa UrrechagaIgartua
Associate Professor

Galdakao-Usansolo Hospital


1981 Bachelor degree in Biochemistry: University of the Basque Country
2008 Researcher Department of Functional and Molecular Biology.University of Oviedo
2010 PhD degree, University of Zaragoza
2011 Associated Professor University of the Basque Country
2014 Tutorial for Medicine Laboratory




Research Interest

  1. Medicine Laboratory
  2. Clinical Analysis technology
  3. Robotics in Hematology
  4. Iron and Anemia
  5. Erythropoiesis
  6. Glycohemoglobin


Professional Activities:

  1. 1.1991 - 1992, the pharmacokinetics laboratory integrated in the Clinical Research Unit of the Hospital Central de Asturias, collaborated in the project's research 91 / 0334, financed by the Fund for health research, study of the pharmacokinetics of the Novantrone.  clinical - pharmacokinetic correlations.
  2. 1996 he worked on the project F.I.S. 93 / 0143 study of the pharmacokinetics of doxorubicin and epirubicin in patients with liver metastases.

Projects funded by the Research Commission (Hospital Galdakao – Usansolo):

  1. Study the mutations of β Thalassemia in the population in the Interior region of Biscay (2002-2004). GlycoHemoglobin in acute coronary syndromes (2006).
  2. New haematological parameters applied to the monitoring of therapy with r-HuEPO  (2007-2008).
  3. New haematological parameters for the study of the metabolism of iron and monitoring of therapy (2010).
  4. Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability in HD patients (2012)



  1. Blue carotenoprotein from the caparace of the crab CarcinusMaenas Comparative Biochemical Physiology (Vol. 77B No. 3, 605-608, 1984). Clinical Pharmacokinetics of high dose DTIC.Cancer Chemotherapy and Pharmacology (Vol. 28 1991) 475-479.
  2. Evaluation of the PRIMUS ULTRA2 HPLC system for the measurement of HbA2 and Β Thalassemia screening,BiochemiaMedica 2008; 18 (3) 351-360
  3. Discriminant  value of % Microcytic / Hypochromic % ratio in the differential diagnosis of microcytic anemia.ClinChem Lab Med 2008; 46 (12): 1752-1758.M/H ratio for the differential diagnosis       of            microcyticanemia:reply.International Journal of Laboratory Hematology 2008; 31 (2): 250 - 1
  4. Red blood cell microcytosis and hypochromia in the differential diagnosis of iron deficiency and Β-thalassaemia trait. International Journal of Laboratory Hematology 2009; 31 (5): 528-534
  5. Clinical utility of the new beckman-coulter parameter red blood cell size factor in the study of erythropoiesis .International Journal of Laboratory Hematology2009;  31(6): 623-629. 
  6. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. ClinChem Lab Med 2009; 47 (11): 1411-6
  7. The new mature red cell parameter, low density of the Beckman-Coulter LH750 haemoglobin: clinical utility in the diagnosis of iron deficiency. International Journal of Laboratory Hematology 2010; 32: e144-e150.
  8. Erythrocyte and reticulocyte indices on the LH 750 as potential markers of functional iron deficiency. Anemia 2010 DOI 10: 1155/2010/625919
  9. The role of automated measurement of red cell subpopulations on the Sysmex XE 5000 analyzer in the differential diagnosis of microcytic anemia.International Journal of Laboratory Hematology 2010; 33: 30-36.
  10. Analysis of reticulocyte parameters on the Sysmex XE 5000 and LH 750 analyzers in the diagnosis of inefficient erythropoiesis. International Journal of Laboratory Hematology 2011; 33: 37-44.
  11. The role of automated measurement of red cell subpopulations in differential diagnosis of microcytic anemia and β thalassemia screening. American Journal of Clinical Pathology. 2011; 135: 374-379.
  12. Erythrocyte and reticulocyte parameters in iron deficiency and thalassemia.Journal of Clinical Laboratory Analysis 2011; 25 (3): 223-228
  13. Low Hemoglobin Density (LHD %) potential marker of iron availability.International Journal of Laboratory Hematology 2012; 34: 47-51Percentage of hypochromic erythrocytes as potential marker of iron availability. ClinChem Lab Med 2012; 50(4):685-687.
  14. Evaluation of ADAMS ™ A1c Menarini HA-8180 HPLC analyzer for HbA1c determination.  Journal of  Life Science USA 2012; 6: 456-460.
  15. High resolution HbA1c separation and Hemoglobinopathy detection by Capillary Electrophoresis. American Journal of Clinical Pathology 2012; 138:448-456
  16. Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability. International Journal of Laboratory Hematology 2013; 35:144-149
  17. Biomarkers of hypochromia:  the contemporary assessment of Iron  status  and erythropoiesis. Biomed Research International 2013. doi: 10.1155/2013/603786.
  18. Multivariable Discriminant Analysis for the Differential Diagnosis of Microcytic Anemia Anemia doi 10.1155/2013/457834
  19. Review: Review and Actualizations of Molecular Genetic Diagnosis, Symptoms, and Diagnostic Strategies of HereditryHemocharomatosis. J Genet Syndr Gene Ther 2013, 4:9 http://dx.doi.org/10.4172/2157-7412.1000184
  20. New parameters for functional iron deficiency assessment. Ann BiolClin 2013: 71 (5); 558-559 Editorial:  Microcytic anemia still a problem in the third millennium. International Journal of Translation & Community Medicine vol 1 (2), 2013.
  21. E Urrechaga. From Wintrobe to the XXI century: A story of inspiration and effort European Medical Journal Hematology 2014; 1:133-137
  22. E. Urrechaga, J.J.M.L. Hoffmann, J.F. Escanero.  From Wintrobe to the XXI century. A Story of Inspiration and Effort, Int J Translation Community Dis 2014;  02(04): 37-41
  23. E. Urrechaga Incidental Detection of HbDisordersduring HbA1c Analysis. Journal of Diabetes Science and Technology 2015; 9(3): 713.
  24. E Urrechaga, JJML Hoffmann, S Izquierdo, JF Escanero. Differential Diagnosis of Microcytic Anemia: the Role of Microcytic and Hypochromic Erythrocytes IntJnlLabHematol 2015; 37:334-340
  25. JJML Hoffmann , E Urrechaga, U Aguirre. Discriminant indices for distinguishing thalassemia and iron deficiency inpatients with microcytic anemia: a meta-analysis. ClinChem Lab Med 2015; 53(12): 1883–1894.


Autoimmune Journal Flyer